Additionally, studies have shown that the CSF of glioma patients contains differentially enriched metabolites such as lactic acid, malic acid, succinate, and phosphoenolpyruvate compared to that of control patients, with variations observed based on the IDH status of GBM patients [279]. The gene discussed is IDH1; the disease is glioma.